Market revenue in 2023 | USD 6,222.1 million |
Market revenue in 2030 | USD 32,516.6 million |
Growth rate | 26.6% (CAGR from 2023 to 2030) |
Largest segment | Diabetes |
Fastest growing segment | Diabetes |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital therapeutics market will help companies and investors design strategic landscapes.
Diabetes was the largest segment with a revenue share of 29.36% in 2023. Horizon Databook has segmented the Global digital therapeutics market based on diabetes, obesity, cvd, respiratory diseases, smoking cessation, cns diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Growing regulatory initiatives are anticipated to propel standardization and R&D in the market over the forecast period. For instance, the Software Pre-Cert Pilot Program is part of the Digital Health Innovation Action Plan of the FDA intended for implying a more efficient governing oversight of software-based medical devices (SaMD) developed by manufacturers.
The program is aimed at developing an efficient regulatory oversight for assessing organizations to establish trust that they can develop high-quality Software-as-a-Medical-Device (SaMD) products. For instance, initiatives, such as the National Digital Health Mission (NDHM), are expected to accelerate the adoption rate of e-healthcare model in India.
Similarly, the &Innovation Strategy 2019-2021& implemented in UAE is driving digital transformation in the healthcare sector.In September 2020, the FDA released a status update for its Software Precertification Program. In this, the FDA specified that it has developed and tested components for the Pre-Cert model and will continue assessing how to integrate the components into a viable product lifecycle approach.
Horizon Databook provides a detailed overview of global-level data and insights on the Global digital therapeutics market , including forecasts for subscribers. This global databook contains high-level insights into Global digital therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Application | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
North America | 996.6 | 1,165.1 | 1,448.9 | 1,725.5 | 2,073.9 | 2,515.3 | 3,078.2 | 3,800.8 | 4,734.7 | 5,949.8 | 7,541.8 | 9,642.4 | 12,433.6 | 25.6% |
Europe | 720.6 | 845.0 | 1,053.9 | 1,258.9 | 1,517.7 | 1,846.4 | 2,266.7 | 2,807.6 | 3,508.7 | 4,423.4 | 5,625.5 | 7,216.2 | 9,336.4 | 26.1% |
Asia Pacific | 452.1 | 543.1 | 693.8 | 848.5 | 1,046.9 | 1,303.1 | 1,636.2 | 2,072.3 | 2,647.3 | 3,410.8 | 4,431.7 | 5,806.7 | 7,671.9 | 28.8% |
Latin America | 131.9 | 157.5 | 200.0 | 243.3 | 298.7 | 369.9 | 462.1 | 582.5 | 740.7 | 950.1 | 1,229.1 | 1,603.6 | 2,110.0 | 28.2% |
MEA | 72.3 | 85.0 | 106.2 | 127.2 | 153.7 | 187.5 | 230.7 | 286.5 | 358.9 | 453.7 | 578.4 | 743.9 | 964.9 | 26.4% |
Overall | 2,373.4 | 2,795.6 | 3,502.9 | 4,203.4 | 5,090.8 | 6,222.1 | 7,673.9 | 9,549.8 | 11,990.3 | 15,187.7 | 19,406.5 | 25,012.8 | 32,516.6 | 26.7% |
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account